SHH · —

Zhejiang Medicine Co., Ltd. (600216.SS) Stock

$11.98 -4.85% SHH: 600216.SS —

—

Valuation

MetricValue
Price$11.98
Market Cap$11.95B
P/E Ratio14.80
P/B Ratio1.01
P/S Ratio1.34
EPS (TTM)$0.84
52-Week High$18.58
52-Week Low$10.94
Dividend Yield2.25%

Financials & Margins

MetricValue
ROE5.54%
ROA3.60%
ROCE—
Gross Margin31.96%
Operating Margin13.73%
Net Margin9.01%
Debt/Equity0.08
Current Ratio4.11

Latest News

Wall St slides after strong jobs report bolsters hawkish Fed bets Reuters · Sep 4, 2026 GoPro Zooms 34% Higher on Starman Optical Merger and Markiplier Stake; Coherent Climbs 7%, Lumentum Gains 3% 24/7 Wall St. · Sep 4, 2026 DaVita Community Care Report 2025: Leading With Integrity and Accountability ACCESS Newswire · Sep 4, 2026 Net Asset Value(s) Business Wire · Sep 4, 2026 Medicare Advantage Lets You In at 65 With No Questions. Medigap Asks Them Forever After. The Switch Most Retirees Can’t Make at 72. 24/7 Wall St. · Sep 4, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio0.69
EV / EBITDA6.03
FCF Yield—
Quick Ratio2.97
Interest Coverage—
Return 1Y-15.75%
Return 3Y12.93%
Return 5Y-17.11%

Ownership

Insiders Held40.92%
Institutions Held4.05%
Institutions Float Held6.86%

About Zhejiang Medicine Co., Ltd.

—

Zhejiang Medicine Co., Ltd. is led by CEO Hongwei Wang, employs 5,417 people, headquartered in Shaoxing, CN, publicly traded since 1999.

Zhejiang Medicine Co., Ltd. (600216.SS) stock trades at $11.98 with a market capitalization of $11.95B. The stock is valued at a price-to-earnings (P/E) ratio of 14.80, price-to-book of 1.01, price-to-sales of 1.34. Over the past 52 weeks the stock has ranged between $10.94 and $18.58, and currently trades 35.5% below its 52-week high. It pays a dividend yielding 2.25%.

On profitability, Zhejiang Medicine Co., Ltd. generates a return on equity (ROE) of 5.54%, an operating margin of 13.73%, a net profit margin of 9.01%.

Official website: www.zmc.top

Zhejiang Medicine Co., Ltd. (600216.SS) — frequently asked questions

What is Zhejiang Medicine Co., Ltd. (600216.SS) stock price today?

Zhejiang Medicine Co., Ltd. (600216.SS) is currently trading at $11.98, down 4.85% today.

What is 600216.SS P/E ratio?

Zhejiang Medicine Co., Ltd.'s P/E ratio is 14.80. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is 600216.SS return on equity (ROE)?

Zhejiang Medicine Co., Ltd.'s return on equity (ROE) is 5.54%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Zhejiang Medicine Co., Ltd.'s market cap?

Zhejiang Medicine Co., Ltd. has a market capitalization of $11.95B.

Does 600216.SS pay a dividend?

Yes. Zhejiang Medicine Co., Ltd. currently yields 2.25%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 600216.SS carry?

Zhejiang Medicine Co., Ltd. has a debt-to-equity ratio of 0.08. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 600216.SS's profit margin?

Zhejiang Medicine Co., Ltd. reports a net profit margin of 9.01% — the share of revenue left after every cost, including tax and interest.

What sector is 600216.SS in?

Zhejiang Medicine Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 600216.SS listed on?

Zhejiang Medicine Co., Ltd. trades on SHH under the ticker 600216.SS.

What is 600216.SS's 52-week range?

Over the last year Zhejiang Medicine Co., Ltd. has traded between $10.94 and $18.58.

Related — Stocks

BSP Bending Spoons S.p.A. $46.63 +5.78% MAIR Madison Air Solutions Corporation $22.92 +0.70% QNT Quantinuum Inc. $37.53 +2.82% USDE StablecoinX Inc. $1.00 -0.01% PURR Hyperliquid Strategies Inc $9.07 +3.30% HBNB Hotel101 Global Holdings Corp. $4.42 -8.45% QMLS QumulusAI, Inc. $3.14 -1.87% HCHL Happy City Holdings Limited $3.96 +0.00% XLAB Exascale Labs Holdings Inc. $3.39 +1.19% VIVO VivoPower PLC $2.45 +1.24%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 600216.SS currently matches

On the figures above, Zhejiang Medicine Co., Ltd. passes the filters for 14 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksLow Debt StocksLarge Cap StocksStocks With PE Under 20Stocks Under $100Stocks Under $50Graham-Style Defensive StocksLarge Cap Dividend StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksLow PE and PB StocksHigh Current Ratio StocksLow Debt Large Cap Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.